Best practice in assessing ototoxicity in children with cancer
- 30 November 2004
- journal article
- editorial
- Published by Elsevier in European Journal Of Cancer
- Vol. 40 (16), 2352-2354
- https://doi.org/10.1016/j.ejca.2004.08.002
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Predicting cisplatin ototoxicity in children: the influence of age and the cumulative doseEuropean Journal Of Cancer, 2004
- Auditory function is unaffected by treatment with ifosfamide in children and adolescentsMedical and Pediatric Oncology, 2000
- Ototoxic Impact of Cisplatin in Pediatric Oncology PatientsThe Laryngoscope, 1999
- Severe ototoxicity following carboplatin-containing conditioning regimen for autologous marrow transplantation for neuroblastomaBone Marrow Transplantation, 1998
- Ifosfamide and exacerbation of cisplatin-induced hearing lossThe Lancet, 1993
- Cisplatin ototoxicity in children: A practical grading systemMedical and Pediatric Oncology, 1991
- Ototoxicity of cisplatinum in children and adolescentsBritish Journal of Cancer, 1990
- Hearing loss in children and young adults receiving cisplatin with or without prior cranial irradiation.Journal of Clinical Oncology, 1989
- Hearing loss in children receiving cisplatin chemotherapyThe Journal of Pediatrics, 1983
- Auditory toxicity effects of long‐term cis‐dichlorodiammineplatinum II therapy in genitourinary cancer patientsJournal of Surgical Oncology, 1981